<?xml version="1.0" encoding="UTF-8"?>
<p>In the opinion of the Infectious Diseases Society of America (IDSA), the published clinical data concerning LPV/r efficacy as COVID-19 treatment are not sufficient to recommend this medicine as treatment, only in a clinical trial context [
 <xref rid="B116-jcm-09-02084" ref-type="bibr">116</xref>].
</p>
